United States

Biopsy Needle Market to hit USD 2.2 billion by 2032, says Global Market Insights Inc.

Biopsy needle industry is predicted to witness 6.6% CAGR between 2023 and 2032 due to technological advancements in biopsy needles and favorable reimbursement scenario

Selbyville, Delaware, Jan. 25, 2023 (GLOBE NEWSWIRE) —

The biopsy needle

Growing cases of infectious illnesses to accelerate the use of biopsy needles

Biopsy needle market share from the infectious diseases segment to record 7% CAGR during 2023 to 2032. The prevalence of biopsy operations using biopsy needles is rising at an exponential rate in tandem with the burden of infectious diseases. Infectious disease is one of the leading causes of death and morbidity worldwide. The need for novel and improved therapies has grown as a result of the COVID-19 pandemic. The aforementioned factors will foster market expansion over the predicted time frame.

Favourable reimbursement policies to accelerate product deployment across hospitals

Growing use of biopsy needles due to an increase in biopsy procedures combined with favourable reimbursement policies will support product deployment across hospitals. A needle biopsy is typically used to confirm the diagnosis before the treatment has been chosen. This makes it possible to treat the patient with greater consideration and to thoroughly check for potential metastatic disease before performing the actual procedure.

Technological advancements to fuel APAC biopsy needle industry growth

Asia Pacific biopsy needle market is predicted to hit over USD 650 million by 2032. Due to the greater growth potential, the region has become a growing market for industry participants. Furthermore, the presence of a large patient population with chronic illnesses and technical improvements in the biopsy instruments, the APAC biopsy needle industry will register promising growth by 2032.

Secure a copy of the premium research report @ https://www.gminsights.com/securecheckout/paymenta/5411?gmpaycod=sugmp 

Strategic expansion efforts to boost biopsy needle industry expansion

Some of the leading companies in the global biopsy needle market include Becton, Medtronic plc, Boston Scientific Corporation, FUJIFILM Holdings Corporation, Dickinson & Company (BD), Becton, Cardinal Health, Hologic Inc, Olympus Corporation, Argon Medical Devices. Inc, Devicor Medical Products, Inc., B. Braun Melsungen AG, Cook Group Incorporated, Stryker Corporation, and INRAD Inc.

Browse Our Reports Store – GMIPulse @  https://www.gminsights.com/gmipulse 

About Global Market Insights

Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.

CONTACT: Contact Us:

Aashit Tiwari
Corporate Sales, USA
Global Market Insights Inc.
Toll Free: +1-888-689-0688
USA: +1-302-846-7766
Europe: +44-742-759-8484
APAC: +65-3129-7718
Email: sales@gminsights.com
Read More News @ https://ibmag.com/

Related Articles

Back to top button